CIC CBIC Certified Infection Control Exam Free Practice Exam Questions (2026 Updated)

The correct answer is D, "Study," as this is the step in the Shewhart/Deming cycle (commonly known as the Plan-Do-Study-Act [PDSA] cycle) where the results of the interventions are compared with the original goal. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the PDSA cycle is a systematic approach to quality improvement, widely used in infection control programs to test and refine interventions. The cycle consists of four stages: Plan (designing the intervention and setting goals), Do (implementing the intervention on a small scale), Study (analyzing the data and comparing outcomes against the original goal), and Act (standardizing successful changes or adjusting based on findings) (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). The Study phase is critical for assessing whether the intervention achieved the intended reduction in infection rates or other performance metrics, providing evidence to guide the next steps.

Option A (Do) involves the execution of the planned intervention, focusing on implementation rather than evaluation, so it does not include comparing results. Option B (Act) is the final step where successful interventions are implemented on a broader scale or adjustments are made, but it follows the comparison made in the Study phase. Option C (Plan) is the initial stage of setting objectives and designing the intervention, which occurs before any results are available for comparison.

The emphasis on the Study phase aligns with CBIC’s focus on using data to evaluate the effectiveness of infection prevention strategies, ensuring that performance improvement projects are evidence-based and goal-oriented (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 - Evaluate the effectiveness of infection prevention and control interventions). This step enables the infection preventionist to determine if the original goal—such as reducing healthcare-associated infections—was met, facilitating continuous improvement.

The scenario describes a potential outbreak of multidrug-resistant Enterococcus faecium in an extended-care facility (ECF) wing, indicated by four positive cultures (including the current case and three prior cases from urine and a draining wound) within a month. The organism exhibits resistance to ampicillin, vancomycin, and penicillin, but sensitivity to linezolid, suggesting a possible vancomycin-resistant Enterococcus (VRE) strain, which is a significant concern in healthcare settings. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the importance of rapid outbreak detection and response in the "Surveillance and Epidemiologic Investigation" domain, aligning with Centers for Disease Control and Prevention (CDC) guidelines for managing multidrug-resistant organisms (MDROs).

Option A, "Notify the medical director of the outbreak," is the most immediate and critical action. Identifying an outbreak—defined by the CDC as two or more cases of a similar illness linked by time and place—requires prompt notification to the facility’s leadership (e.g., medical director) to initiate a coordinated response. The presence of four Enterococcus cases, including a multidrug-resistant strain, within a single ECF wing over a month suggests a potential cluster, necessitating urgent action to assess the scope, implement control measures, and allocate resources. The CDC’s "Management of Multidrug-Resistant Organisms in Healthcare Settings" (2006) recommends immediate reporting to facility leadership as the first step to activate an outbreak investigation team, making this the priority.

Option B, "Compare the four culture reports and sensitivity patterns," is an important subsequent step in outbreak investigation. Analyzing the antibiotic susceptibility profiles and culture sources can confirm whether the cases are epidemiologically linked (e.g., clonal spread of VRE) and guide treatment and control strategies. However, this is a detailed analysis that follows initial notification and should not delay alerting the medical director. Option C, "Conduct surveillance cultures for this organism in all residents," is a proactive measure to determine the prevalence of Enterococcus faecium, especially VRE, within the wing. The CDC recommends targeted surveillance during outbreaks, but this requires prior authorization and planning by the outbreak team, making it a secondary action after notification. Option D, "Notify the nursing administrator to close the wing to new admissions," may be a control measure to prevent further spread, as suggested by the CDC for MDRO outbreaks. However, closing a unit is a significant decision that should be guided by the medical director and infection control team after assessing the situation, not an immediate independent action by the IP.

The CBIC Practice Analysis (2022) and CDC guidelines prioritize rapid communication with leadership to initiate a structured outbreak response, including resource allocation and policy adjustments. Given the multidrug-resistant nature and cluster pattern, notifying the medical director (Option A) is the most immediate and appropriate action to ensure a comprehensive response.

There is no strong evidence that isolating infected cases in a separate surgical suite reduces SSI risk.

Step-by-Step Justification:

SSI Prevention Strategies Supported by Evidence:

Preoperative hospital stay limitation reduces exposure to hospital-acquired pathogens​.

Antimicrobial preoperative scrubs lower bacterial load on the skin​.

Adequate nutrition improves immune function and wound healing​.

Why Designating a Separate Surgical Suite Is Not Effective:

Operating room environmental controls (e.g., laminar airflow, sterilization protocols) are more important than suite designation.

No significant reduction in SSIs has been observed by segregating infected cases into specific OR suites​.

Why Other Options Are Correct:

A. Limiting preoperative hospital stay: Reduces nosocomial bacterial exposure.

B. Antimicrobial preoperative scrub: Decreases skin flora contamination.

C. Assuring adequate patient nutrition: Enhances immune defense against infections.

CBIC Infection Control References:

APIC Text, "Surgical Site Infection Prevention Strategies"​.

Among the listed pathogens, Hepatitis C has the highest risk of seroconversion following a percutaneous exposure, though it's important to note that Hepatitis B actually has the highest overall risk. However, since Hepatitis B is not listed among the options, the correct choice from the available ones is Hepatitis C.

The APIC Text confirms:

“The average risk of seroconversion after a percutaneous injury involving blood infected with hepatitis C virus is approximately 1.8 percent”.

The other options are not bloodborne pathogens typically associated with high seroconversion risks after needlestick or percutaneous exposure:

A. Shigella – transmitted fecal-orally, not percutaneously.

B. Syphilis – transmitted sexually or via mucous membranes.

C. Hepatitis A – primarily fecal-oral transmission, low occupational seroconversion risk.

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that microfiber cleaning materials are preferred over traditional cotton cloths and mops because of their electrostatic properties, which enhance cleaning effectiveness. Microfiber is composed of very fine synthetic fibers that become positively charged, allowing them to attract and trap negatively charged dirt, dust, and microorganisms rather than simply pushing them across surfaces.

This electrostatic attraction enables microfiber to remove a significantly higher percentage of bacteria and organic material from surfaces compared to cotton, even when used with less cleaning solution or disinfectant. The split fiber structure also increases surface area, allowing microorganisms and debris to be captured within the fibers rather than redistributed. These properties make microfiber particularly effective for environmental cleaning in healthcare settings, where surface contamination contributes to transmission of healthcare-associated infections.

Option A is incorrect because microfiber products are often more expensive initially, though they may be cost-effective over time. Option C is incorrect because microfiber must be laundered separately under specific conditions to maintain effectiveness. Option D may be true but is not the primary reason for preference.

For the CIC® exam, it is important to recognize that microfiber’s positive charge and superior ability to attract and retain microorganisms are the key reasons it is favored over cotton for environmental cleaning and infection prevention.

The CBIC Certified Infection Control Exam Study Guide (6th edition) aligns with CDC guidance regarding interpretation of the tuberculin skin test (TST) in healthcare personnel. For a healthy individual with no known risk factors for tuberculosis, a TST is considered positive only when induration is ≥10 mm. In this scenario, the employee’s TST result of 7 mm induration is negative and does not meet the threshold for latent TB infection.

A prior history of BCG vaccination does not change interpretation criteria in adults. The CDC explicitly recommends that TST results be interpreted regardless of BCG history, as vaccine-related reactivity typically wanes over time and induration should not be attributed to BCG alone. Therefore, a 7 mm reaction in a low-risk, asymptomatic healthcare worker does not require further diagnostic evaluation.

Option A (chest x-ray) is reserved for individuals with a positive TB test or symptoms suggestive of active TB. Option C (repeat testing) is not indicated unless this was part of a two-step baseline test and the first result was negative in a newly hired employee, which is not the case here. Option D is inappropriate because treatment is only considered after confirmed latent TB infection.

For the CIC® exam, it is essential to recognize that no further action is required when TST induration is below the positive threshold for the individual’s risk category, even in those with prior BCG vaccination.

Properly written instructional objectives are a fundamental component of effective education programs and are emphasized in the Education and Research domain of the CBIC Certified Infection Control Exam Study Guide (6th edition). Instructional objectives are designed to clearly state what the learner will be able to do after completing an educational activity. The Study Guide highlights that objectives must be learner-centered, measurable, and observable, which is best achieved by using clear action-oriented verbs.

Describing learner outcomes using action words—such as identify, analyze, demonstrate, apply, or evaluate—allows educators to define expected performance and assess whether learning has occurred. These action words are typically aligned with Bloom’s taxonomy and support evaluation of cognitive, psychomotor, or affective learning domains. This approach ensures that education is outcome-driven rather than content-driven.

Option A is incorrect because communicating the intent of the program is the purpose of a program goal, not an instructional objective. Option C is unrelated to instructional design; continuing education unit eligibility is determined by accrediting bodies, not by objectives themselves. Option D is incorrect because instructional objectives are not limited to knowledge and application levels; they may address higher-order thinking skills such as analysis, synthesis, and evaluation.

For CIC® exam preparation, recognizing that instructional objectives must be written in measurable, action-oriented terms is essential, as this principle directly supports effective education, competency validation, and performance improvement in infection prevention programs.

==========

aQUESTION NO: 5

Following an aerosol release of anthrax, a hospital distributes antibiotic prophylaxis to all of its employees and their family members but not to members of the general public. What is the hospital implementing?

A. Closed point of dispensing

B. Hospital incident command

C. Occupational health policy

D. Syndromic surveillance

Answer: A

In the context of a biologic emergency such as an aerosolized release of anthrax, rapid distribution of prophylactic medications is a critical preparedness function. The CBIC Certified Infection Control Exam Study Guide (6th edition) describes a closed point of dispensing (POD) as a mechanism by which an organization dispenses medications or vaccines to a defined, non-public population, such as employees and their families, rather than the general public.

Hospitals commonly serve as closed PODs during public health emergencies to ensure continuity of operations. By providing antibiotic prophylaxis to healthcare workers and their household contacts, the hospital reduces absenteeism, protects its workforce, and maintains its ability to deliver patient care during a crisis. This approach is typically coordinated with public health authorities but is operationally managed by the organization for its designated population.

The other options do not best fit the scenario. Hospital incident command is a management structure used to coordinate response activities but does not specifically describe medication distribution. An occupational health policy governs routine employee health practices and does not extend to family members during emergency prophylaxis. Syndromic surveillance refers to monitoring data for early detection of outbreaks, not to dispensing antibiotics.

Closed POD operations are a key component of emergency preparedness and bioterrorism response planning, and recognition of this concept is essential for CIC® exam candidates.

==========

The correct answer is D, "Cost benefit analysis and safety considerations," as this provides the best information to support the selection of a new catheter aimed at decreasing the rate of catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, selecting medical devices like catheters for infection prevention involves a comprehensive evaluation that balances efficacy, safety, and economic impact. A cost-benefit analysis assesses the financial implications (e.g., reduced infection rates leading to lower treatment costs) against the cost of the new catheter, while safety considerations ensure the device minimizes patient risk, such as reducing biofilm formation or irritation that contributes to CAUTIs (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This dual focus provides evidence-based data to justify the catheter’s adoption, aligning with the goal of improving patient outcomes and reducing healthcare-associated infections (HAIs).

Option A (staff member preference and product availability) is subjective and logistical rather than evidence-based, making it insufficient for a decision that impacts infection rates. Option B (product materials and vendor information) offers technical details but lacks the broader context of efficacy and cost-effectiveness needed for a comprehensive evaluation. Option C (value analysis and information provided by the manufacturer) includes a structured assessment of value, but it may be biased toward the manufacturer’s claims and lacks the independent safety and cost-benefit perspective critical for infection prevention decisions.

The emphasis on cost-benefit analysis and safety considerations reflects CBIC’s priority on using data-driven and patient-centered approaches to select interventions that enhance infection control (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies). This approach ensures the catheter’s selection is supported by robust evidence, optimizing both clinical and economic outcomes in the prevention of CAUTIs.

A critical principle emphasized in the Certification Study Guide (6th edition) is that instrument reprocessing begins at the point of use, not in the sterile processing department. Immediate removal of gross soil and organic material—referred to as bioburden—prevents drying of blood, tissue, and other debris on instruments. Dried organic material significantly interferes with subsequent cleaning, disinfection, and sterilization processes, reducing the effectiveness of these steps and increasing the risk of surgical site infections.

The study guide explains that instruments should be kept moist or damp after use, typically by using an approved enzymatic spray, damp towel, or transport container, to prevent soil from adhering firmly to surfaces and lumens. This practice protects both the integrity of the instruments and the safety of personnel handling them. Delaying cleaning or allowing instruments to dry increases microbial load and biofilm formation, which are difficult to remove during later processing stages.

The incorrect options conflict with infection prevention standards: holding dirty instruments increases contamination risk; wrapping instruments in pads does not address bioburden; and sending instruments for sorting without point-of-care decontamination violates best practices. Proper point-of-care treatment is foundational to safe, effective sterile processing and is consistently tested on the CIC exam.

Early detection of emerging public health threats depends on receiving timely, actionable information that can trigger rapid assessment and response within the facility. The Certification Study Guide emphasizes preparedness for biologic threats and emerging infectious diseases as part of core infection prevention practice (e.g., planning for an influx of patients with communicable diseases and responding to emerging infections). Subscribing to public health alerts is the most effective option because alerts are designed to push critical updates (case definitions, exposure risks, recommended control measures, and reporting expectations) as soon as they are identified by public health authorities—minimizing delay compared with periodically checking websites.

Why the other options are incorrect:

A is reactive and can miss urgent updates between scheduled checks.

C supports ongoing education but is not a real-time early warning system.

D is important for facility-level detection, but emerging threats are often identified first through public health surveillance and communications beyond a single facility’s lab.

Ongoing education for Infection Preventionists (IPs) is essential due to the rapidly evolving healthcare landscape and emergence of new infectious diseases, regulations, and technologies.

From the APIC Text:

“Professional development is essential to keeping the infection preventionist up to date with the latest knowledge, skills, and strategies for preventing infections.”

The APIC/JCR Workbook also notes:

“Because information related to emerging infectious diseases... changes rapidly... IPs should actively review information for updates and guidance.”

Reviewing compliance with VAP prevention bundles (e.g., head-of-bed elevation, oral care, sedation breaks) is the first step in outbreak control​.

Preemptive antibiotics (B) are not recommended due to antibiotic resistance risks.

Negative pressure rooms (C) are not required for VAP.

Ventilator circuit cultures (D) do not guide patient management.

CBIC Infection Control References:

APIC Text, "VAP Prevention Measures," Chapter 11​.

Documentation of each steam sterilization cycle is a regulatory and quality requirement. It must include load contents, the sterilizer ID, date, cycle number, and the person who assembled the load. These details support traceability and quality assurance.

The APIC Text states:

“Each item or package should be labeled with a lot-control identifier that includes the sterilizer identification number or code, a detailed list of the contents, an identifier for the person who assembled the package, the date of sterilization, the cycle number...”

Other options like the machine model number or date sterilizer was cleaned are not routine documentation elements for every cycle.

Benchmarking compares infection rates across healthcare facilities. For accurate benchmarking, case definitions must be standardized and adjusted for patient demographics, severity of illness, and other risk factors.

Why the Other Options Are Incorrect?

A. Data collectors are trained on how to collect data – Training is necessary, but it does not directly ensure comparability between facilities.

B. Collecting data on a small population – A larger sample size increases accuracy and reliability in benchmarking.

C. Denominator rates selected based on an organizational risk assessment – Risk assessment is important, but standardized case definitions are critical for comparison.

CBIC Infection Control Reference

According to APIC, accurate benchmarking relies on using standardized case definitions that account for differences in patient populations​.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that a critical initial step in any outbreak investigation is for the infection preventionist to develop a strong understanding of the organism involved, its epidemiology, reservoirs, modes of transmission, and previously reported outbreak sources. Conducting a literature search of similar outbreak investigations provides this foundational knowledge and helps guide a structured, evidence-based investigation.

Pseudomonas aeruginosa is an opportunistic, water-associated pathogen frequently implicated in healthcare-associated outbreaks, particularly in ICUs. Prior outbreak investigations described in the literature commonly identify sources such as sink drains, faucets, respiratory equipment, humidifiers, contaminated medications, and inadequate reprocessing of medical devices. Reviewing published investigations allows the IP to anticipate likely sources, identify high-yield environmental sampling locations, and avoid unnecessary or unfocused interventions.

Options A and D may become appropriate later, depending on outbreak magnitude and reporting requirements, but they are not the initial step. Option B can be helpful but relies on anecdotal experience rather than systematic evidence. The Study Guide stresses that outbreak investigations should begin with background research and hypothesis generation, followed by targeted data collection and analysis.

For the CIC® exam, this question reinforces that effective outbreak management starts with understanding what is already known, making a literature review the most appropriate initial action.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that when a potential cluster of infections is identified, the first priority is situational awareness. Before implementing control measures or advanced laboratory analysis, the infection preventionist must determine whether the cases are epidemiologically linked. Identifying the location of the patients—such as whether they are on the same unit, service, or clinic—is the essential first step in assessing the likelihood of transmission or a common source.

Option C is correct because determining patient location allows the IP to evaluate spatial and temporal relationships, which form the foundation of outbreak investigation. If the patients are colocated, this may indicate shared staff, equipment, or environmental exposure, guiding immediate and targeted interventions.

Cohorting patients (Option A) is premature without confirming proximity or transmission risk. Monitoring hand hygiene (Option B) is an important control measure but should follow confirmation of potential spread or shared risk factors. Pulsed-field gel electrophoresis (Option D) is an advanced molecular typing method and is never an initial step; it is reserved for later stages when epidemiologic evidence suggests related cases.

For the CIC® exam, this question tests understanding of outbreak investigation sequencing. The Study Guide consistently reinforces that defining who, where, and when comes before interventions or laboratory typing, making determination of patient location the correct first action.

The correct answer is C, "Ambulance personnel should be evaluated for possible exposure," as this statement is true regarding the need for evaluating exposure to communicable illness. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the presence of Gram negative diplococci in a cerebral spinal fluid (CSF) specimen is suggestive of a serious bacterial infection, most likely Neisseria meningitidis, which causes meningococcal disease. This condition is highly contagious and can be transmitted through respiratory droplets or direct contact with respiratory secretions, particularly during procedures like intubation (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.1 - Identify infectious disease processes). The patient was intubated during ambulance transport, creating a potential aerosol-generating procedure (AGP) that could have exposed ambulance personnel to infectious droplets before Droplet Precautions were instituted upon arrival at the Emergency Department (ED). Therefore, evaluating ambulance personnel for possible exposure is necessary to assess their risk and determine if post-exposure prophylaxis (e.g., antibiotics) or monitoring is required.

Option A (follow-up evaluation is not required for this laboratory finding) is incorrect because the identification of Gram negative diplococci in CSF is a critical finding that warrants investigation due to the potential for meningococcal disease, a reportable and transmissible condition. Option B (ED personnel should be evaluated for possible exposure) is less applicable since the patient was immediately placed in Droplet Precautions upon ED admission, minimizing exposure risk to ED staff after that point, though it could be considered if exposure occurred before precautions were fully implemented. Option D (follow-up evaluation is not necessary as the appropriate precautions were promptly instituted) is inaccurate because the prompt institution of Droplet Precautions in the ED does not retroactively address the exposure risk during ambulance transport, where precautions were not in place.

The focus on evaluating ambulance personnel aligns with CBIC’s emphasis on identifying and mitigating transmission risks associated with communicable diseases, particularly in high-risk settings like ambulance transport (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). This step is supported by CDC guidelines, which recommend exposure evaluation and prophylaxis for close contacts of meningococcal disease cases (CDC Meningococcal Disease Management, 2021).

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies the anterior nares (nose) as the most common and reliable site for colonization with Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). During suspected outbreaks, culturing the nares is the most effective method for identifying persistent carriers, particularly among healthcare personnel or patients who may serve as reservoirs for transmission.

Nasal carriage of S. aureus is well established in epidemiologic literature and infection prevention practice. Individuals may be persistent carriers, intermittent carriers, or non-carriers, with persistent nasal carriers posing the highest risk for transmission and subsequent infection. The Study Guide emphasizes that nasal colonization strongly correlates with both endogenous infection risk and spread to others, making it the preferred screening site during outbreak investigations.

Hands (Option B) may transiently harbor S. aureus, but hand contamination is temporary and highly variable, making it less useful for identifying long-term carriers. Throat (Option C) and rectum (Option D) are not primary colonization sites for S. aureus and are not routinely used in outbreak screening unless specifically indicated by epidemiologic data.

For CIC® exam purposes, this question reinforces a core infection prevention principle: the anterior nares are the primary reservoir for Staphylococcus aureus, and nasal cultures are the most effective method for identifying carriers during outbreak investigations.

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly distinguishes true infection from pseudo-infection and colonization, particularly when interpreting urine culture results. A pseudo-infection refers to a positive laboratory result that does not represent a true clinical infection and is often associated with asymptomatic bacteriuria, specimen contamination, or improper collection.

When a patient has a positive urine culture but reports no urinary or systemic symptoms, the most accurate interpretation is that the finding represents colonization or a pseudo-infection rather than a true urinary tract infection (UTI). The Study Guide emphasizes that UTIs must meet both microbiologic and clinical criteria. Symptoms such as dysuria, urinary frequency, urgency, suprapubic tenderness, flank pain, or costovertebral angle tenderness are required to support a diagnosis of infection.

Options A, C, and D all describe symptoms consistent with upper or lower urinary tract infection and therefore suggest true infection rather than pseudo-infection. In contrast, the absence of symptoms strongly supports a diagnosis of asymptomatic bacteriuria or pseudo-infection, for which antimicrobial treatment is generally not indicated, except in specific populations (e.g., pregnant patients or those undergoing urologic procedures).

Recognizing pseudo-infection is critical for antimicrobial stewardship, prevention of unnecessary antibiotic use, and accurate infection surveillance—key competencies tested on the CIC® exam.